Hungarian Biotech Database

Biotechgate

Biotechgate Global Database › Global Trial › Global Log-in ›

Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry
Results 1 - 20 out of 66 displayed.
1 2 3 4 »

Sanofi to present oncology strategy, provide update on portfolio and emerging pipeline

Read more ››

By: GlobenewsWire - 02 Jun 2020

Sanofi announces closing of Regeneron stock sale

Read more ››

By: GlobenewsWire - 29 May 2020

Libtayo® (cemiplimab-rwlc) longer-term results in advanced cutaneous squamous cell carcinoma presented at ASCO 2020 show durable responses that deepen over time

Read more ››

By: GlobenewsWire - 29 May 2020

Sanofi names new leaders to Executive Committee

Read more ››

By: GlobenewsWire - 29 May 2020

Sanofi’s Board of Directors notes the resignation of Emmanuel Babeau and coopts Gilles Schnepp as Independent Director

Read more ››

By: GlobenewsWire - 28 May 2020

Sanofi announces pricing of Regeneron stock offering

Read more ››

By: GlobenewsWire - 27 May 2020

Sanofi: FDA approves Dupixent® (dupilumab) as first biologic medicine for children aged 6 to 11 years with moderate-to-severe atopic dermatitis

Read more ››

By: GlobenewsWire - 26 May 2020

Sanofi: information concerning the total number of voting rights and shares, April 2020

Read more ››

By: GlobenewsWire - 25 May 2020

Sanofi intends to sell its equity investment in Regeneron; confirms no change to ongoing collaboration

Read more ››

By: GlobenewsWire - 25 May 2020

Sanofi to highlight pipeline programs in a series of interactive virtual sessions leading to a R&D day event

Read more ››

By: GlobenewsWire - 18 May 2020

FDA grants priority review of sutimlimab, potential first approved treatment of hemolysis in adult patients with Cold Agglutinin Disease

Read more ››

By: GlobenewsWire - 14 May 2020

Sarclisa® (isatuximab) Phase 3 IKEMA trial meets primary endpoint early in patients with relapsed multiple myeloma

Read more ››

By: GlobenewsWire - 12 May 2020

Libtayo® (cemiplimab) shows clinically meaningful and durable responses in second-line advanced basal cell carcinoma

Read more ››

By: GlobenewsWire - 05 May 2020

Sanofi: information concerning the total number of voting rights and shares, March 2020

Read more ››

By: GlobenewsWire - 03 May 2020

Sanofi: Annual General Meeting of April 28, 2020

Read more ››

By: GlobenewsWire - 28 Apr 2020

Sanofi : INFORMATION ON THE FINAL TERMS OF DEPARTURE OF OLIVIER BRANDICOURT, FORMER CHIEF EXECUTIVE OFFICER

Read more ››

By: GlobenewsWire - 28 Apr 2020

Sanofi and Regeneron provide update on U.S. Phase 2/3 adaptive-designed trial in hospitalized COVID-19 patients

Read more ››

By: GlobenewsWire - 27 Apr 2020

Sanofi: Phase 3 trial of Libtayo® (cemiplimab) as monotherapy for first-line advanced non-small cell lung cancer stopped early due to highly significant improvement in overall survival

Read more ››

By: GlobenewsWire - 27 Apr 2020

Sanofi at forefront of fight against COVID-19 in Q1 2020

Read more ››

By: GlobenewsWire - 24 Apr 2020

FDA approves MenQuadfiTM, the latest innovation in meningococcal (MenACWY) vaccination

Read more ››

By: GlobenewsWire - 24 Apr 2020

Looking for companies outside of Hungary?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

June 2020
- Digital RESI – Three Day Conference
- BIO Digital
- Brussels: The Pharma Business Development Course

Add an Event »

Latest company news

Sanofi to present oncology strategy, provide update on portfolio and emerging pipeline
02 Jun 2020 (GlobenewsWire)

Sanofi announces closing of Regeneron stock sale
29 May 2020 (GlobenewsWire)

Libtayo® (cemiplimab-rwlc) longer-term results in advanced cutaneous squamous cell carcinoma presented at ASCO 2020 show durable responses that deepen over time
29 May 2020 (GlobenewsWire)

Biotechgate database

About Biotechgate
The Hungarian Biotech Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com